BIOHEMP INTERNATIONAL, INC.
CIK 0001556416
Revenue (TTM)
—
Q3 May 2019
Net Income (TTM)
−$39.66K
+59.2% YoY
Q3 May 2019
EPS Diluted (TTM)
—
Q3 May 2019
Gross Margin
—
Q3 May 2019
Operating Margin
—
Q3 May 2019
Net Margin
—
Q3 May 2019
Free Cash Flow (TTM)
—
Q3 May 2019
Cash
$84
Q3 May 2019
Total Debt
—
Q3 May 2019
Shares Outstanding
2.49M sh
Q3 May 2019
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.